Form 483

Fresenius Medical Care Andina S.A.S. Form 483, 2026-06-02

FDA issued a Form 483 to Fresenius Medical Care Andina S.A.S. on 2026-06-02 with 8 public-safe observations.

483· Form 483 issuedHuman Drugs8 observations

Fresenius Medical Care Andina S.A.S. · Cota, Colombia · Issued June 2, 2026

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Jun 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Justin A Boyd, Martin M Kimani

2 Jun 2026
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Justin A Boyd, Martin M Kimani

2 Jun 2026
21 CFR 211.170(b)

Annual visual exams of drug products

Cited by Justin A Boyd, Martin M Kimani

2 Jun 2026
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Justin A Boyd, Martin M Kimani

2 Jun 2026
21 CFR 211.194(a)

Complete test data included in records

Cited by Justin A Boyd, Martin M Kimani

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(5)Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 8 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere